A new study says nanoparticle delivery of narasin, an antibiotic compound, could work effectively against drug-resistant bacteria that cause Acne vulgaris.
An antibacterial compound delivered inside microscopic envelopes could soon bring relief to hundreds of millions with the inflammatory skin condition acne vulgaris.